title: Is off-label use of BMP in pediatric spine surgery now a standard of care? Commentary on an article by Amit Jain, MD, et al.: "Factors associated with use of bone morphogenetic protein during pediatric spinal fusion surgery. an analysis of 4817 patients".
authors.affiliation: Sanford Orthopedics and Sports Medicine, Sanford Children's Hospital, Sioux Falls, South Dakota, USA.
authors.forename: Geoffrey F
authors.initials: GF
authors.lastname: Haft
mesh_terms: D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D016025:Bone Transplantation / Q000379:methods*; D005260:Female; D006801:Humans; D008159:Lumbar Vertebrae / Q000601:surgery*; D008297:Male; D013122:Spinal Diseases / Q000601:surgery*; D013123:Spinal Fusion / Q000379:methods*; D013904:Thoracic Vertebrae / Q000601:surgery*
chemical_list: D019485:Bone Morphogenetic Proteins